By Counterforce Health Team in Xenpozyme (olipudase alfa-rpcp) —

How to Get Xenpozyme (Olipudase Alfa) Covered by Cigna in Florida: Complete PA Guide and Appeal Process

Answer Box: Getting Xenpozyme Covered by Cigna in Florida

Xenpozyme (olipudase alfa) requires prior authorization from Cigna in Florida. You'll need confirmed ASMD diagnosis via enzyme testing, specialist prescription, and baseline assessments. Submit through Cigna's provider portal with genetic/enzyme results, clinical documentation, and medical necessity letter. If denied, you have 180 days for internal appeal and can request expedited 72-hour review for urgent cases. External review through Florida DFS is available after internal appeals.

First step today: Contact your metabolic specialist to gather enzyme assay results and initiate prior authorization paperwork through Cigna's provider portal.

Table of Contents

Cigna Plan Types in Florida

Understanding your specific Cigna plan affects how you access Xenpozyme and specialty care in Florida:

Plan Type Specialist Referrals Network Requirements Prior Authorization
HMO Required from PCP In-network only (except emergencies) Required for specialty drugs
EPO No referrals needed In-network only (except emergencies) Required for specialty drugs
PPO No referrals needed In- and out-of-network coverage Required for specialty drugs

Key insight: All Cigna plans in Florida require prior authorization for Xenpozyme, but EPO and PPO plans allow direct access to metabolic specialists without PCP referrals, potentially speeding the approval process.

Note: Florida Cigna members with HMO plans must ensure their chosen PCP can refer to in-network genetic/metabolic specialists familiar with ASMD.

Xenpozyme Formulary Status

Cigna places Xenpozyme on specialty tier formularies with strict medical necessity criteria. The medication requires:

  • Confirmed ASMD diagnosis established by laboratory testing
  • Prescription by specialist experienced in metabolic disorders
  • Prior authorization approval before dispensing
  • Specialty pharmacy dispensing through Cigna's network (typically Accredo)

No alternatives: Unlike many specialty drugs, there are no FDA-approved alternatives to Xenpozyme for ASMD, making appeal success particularly important when initial requests are denied.

Prior Authorization Requirements

Clinical Documentation Required

Diagnostic Confirmation:

Baseline Assessments:

  • Spleen volume (MRI): ≥5 multiples of normal (pediatric) or ≥6 multiples (adults)
  • Diffusing capacity (DLco): ≤70% predicted for adults
  • Platelet count and liver function tests
  • Height Z-score ≤-1 for pediatric patients

Prescriber Requirements:

  • Must be metabolic specialist, geneticist, hepatologist, or pulmonologist
  • Or primary care physician consulting with specialist

Coverage at a Glance

Requirement What It Means Where to Find It
PA Required All requests need approval Cigna Coverage Policy
Specialty Tier Higher cost-sharing Member formulary document
Network Pharmacy Must use Accredo or approved pharmacy Cigna provider portal
Quantity Limits FDA-approved dosing only Drug policy guidelines
Diagnosis Codes ICD-10: E75.240-E75.249 Clinical documentation

Specialty Pharmacy Process

Cigna partners with Accredo for Xenpozyme dispensing. Once PA is approved:

  1. Prescription routing: Your doctor sends prescription to Accredo
  2. Patient enrollment: Accredo contacts you for insurance verification and delivery setup
  3. Coordination: Accredo handles insurance billing and delivery scheduling
  4. Ongoing support: Clinical pharmacists provide injection training and monitoring

Contact: Accredo Specialty Pharmacy at 1-800-803-2523

Tip: Establish your Accredo account early in the PA process to avoid delays once approval is received.

Cost-Share Basics

Xenpozyme costs approximately $1,515-$7,576 per vial depending on strength. Your out-of-pocket costs depend on:

  • Deductible: May apply to specialty tier medications
  • Coinsurance: Typically 20-40% for specialty drugs after deductible
  • Out-of-pocket maximum: Annual limit on your total costs

Financial assistance options:

Submission Process

Step-by-Step: Fastest Path to Approval

  1. Gather documentation (Patient/Clinic): Enzyme test results, genetic testing, baseline imaging, specialist consultation notes
  2. Complete PA form (Clinic): Submit through Cigna provider portal or fax with all required clinical information
  3. Medical necessity letter (Specialist): Include diagnosis confirmation, symptom documentation, treatment rationale
  4. Submit to Cigna (Clinic): Via provider portal, fax, or mail with complete documentation package
  5. Follow up (Patient/Clinic): Track submission status through provider portal or member services
  6. Receive determination (All): Cigna provides written decision typically within 14 business days
  7. If approved (Patient): Coordinate with Accredo for prescription fulfillment and delivery

Expected timeline: 14 business days for standard review, 72 hours for expedited urgent cases.

Common Approval Patterns

Clinician Corner: Medical Necessity Letter Essentials

Strong submissions include:

Problem statement:

  • Clear ASMD diagnosis with enzyme activity levels
  • Specific non-CNS symptoms and functional impact
  • Disease progression documentation

Clinical rationale:

  • Why Xenpozyme is medically necessary
  • Expected treatment outcomes
  • Monitoring plan for safety and efficacy

Supporting evidence:

Common Denial Reasons & Solutions

Denial Reason How to Address
Insufficient diagnosis documentation Submit complete enzyme assay and genetic testing results
Lack of specialist involvement Obtain consultation notes from metabolic specialist
Missing baseline assessments Complete required imaging and laboratory studies
Inadequate medical necessity Strengthen letter with symptom documentation and treatment rationale

Appeals Process for Florida

Internal Appeals

Timeline: 180 days from denial notice to file appeal Process:

  1. Submit appeal via Cigna member portal or in writing
  2. Include denial letter, additional medical documentation, and updated clinical information
  3. Request peer-to-peer review between your specialist and Cigna medical director

Expedited appeals: For urgent cases, Cigna must decide within 72 hours

External Review (Florida)

If internal appeals fail, Florida offers independent external review:

Eligibility: After completing internal appeal process Timeline: Request within 4 months of final internal denial Process: File with Florida Department of Financial Services Cost: Free to patients Decision: Binding on Cigna if reviewer approves coverage

For urgent cases: External review decision within 72 hours

Contact: Florida Insurance Consumer Helpline at 1-877-693-5236

When to Escalate

Contact Florida regulators if:

  • Cigna doesn't follow required appeal timelines
  • You're not receiving proper appeal rights information
  • There are procedural violations in the review process

FAQ

How long does Cigna prior authorization take in Florida? Standard PA decisions take up to 14 business days. Expedited reviews for urgent cases are decided within 72 hours.

What if Xenpozyme is non-formulary on my plan? Submit a formulary exception request with medical necessity documentation. All Cigna plans must have an exception process for non-covered medications.

Can I request an expedited appeal? Yes, if delay in treatment could seriously jeopardize your health. Both internal appeals and external reviews offer expedited timelines of 72 hours.

Does step therapy apply to Xenpozyme? Step therapy typically doesn't apply since there are no FDA-approved alternatives for ASMD. However, Cigna may require documentation of supportive care attempts.

What happens if I move from Florida to another state? Appeal rights and external review processes vary by state. Contact your new state's insurance department for specific procedures.

Can my doctor request a peer-to-peer review? Yes, your specialist can request to speak directly with Cigna's medical director during the appeal process. This often helps clarify clinical rationale.

About Counterforce Health

Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into successful appeals. Our platform analyzes denial letters and plan policies to create targeted, evidence-backed rebuttals that align with each payer's specific requirements. For complex cases like Xenpozyme appeals, we help identify the exact denial basis and draft point-by-point responses using the right clinical evidence and procedural requirements.

Sources & Further Reading

This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance company for guidance specific to your situation. Insurance policies and procedures can change; verify current requirements with Cigna and Florida regulatory authorities.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.